Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06133231 · ClinicalTrials.gov registry record · NA
Optimizing Research With Diverse Families - Feasibility and Acceptability Study (FAST)
A NA study of Attention Deficit/Hyperactivity Disorder and Irritable Mood, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06133231 is a NA study of Attention Deficit/Hyperactivity Disorder and Irritable Mood that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 30 participants, below the 297-participant average among 13 other Attention Deficit/Hyperactivity Disorder trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06133231, a NA study of Attention Deficit/Hyperactivity Disorder and Irritable Mood, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluate feasibility and acceptability of recruiting Black and Hispanic families for an open label clinical trial of multinutrients while collecting real-time parent-reported child behavior data and collecting at-home biospecimens to explore their potential as biomarkers, in a study of pediatric ADHD.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Multinutrients; a 36-ingredient blend of vitamins, minerals, amino acids, and antioxidants
Study Locations (1)
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-01-06 |
| Est. Completion | 2026-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06133231
The ClinicalTrials.gov registry entry for NCT06133231 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 297-participant average among 13 other Attention Deficit/Hyperactivity Disorder trials with a reported enrollment target (90% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Attention Deficit/Hyperactivity Disorder appearing as the primary indexed condition, and to 1 intervention - of which Multinutrients; a 36-ingredient blend of vitamins, minerals, amino acids, and antioxidants is the first listed.
NCT06133231 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT06133231 about?
NCT06133231 is a clinical study titled "Optimizing Research With Diverse Families - Feasibility and Acceptability Study (FAST)". Evaluate feasibility and acceptability of recruiting Black and Hispanic families for an open label clinical trial of multinutrients while collecting real-time parent-reported child behavior data and collecting at-home biospecimens to explore their potential as biomarkers, in a study of pediatric ADH...
What is the current status of trial NCT06133231?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-01-06. Estimated completion is 2026-01.
What conditions does trial NCT06133231 study?
This clinical trial studies the following conditions: Attention Deficit/Hyperactivity Disorder, Irritable Mood, Emotional Dysfunction.
What interventions are being tested in trial NCT06133231?
The interventions under investigation include: Multinutrients; a 36-ingredient blend of vitamins, minerals, amino acids, and antioxidants (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06133231?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06133231 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Attention Deficit/Hyperactivity Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Pilot Study of a Remote ADHD Monitoring Program
RECRUITING · NA
-
Focus Groups in Ethnically and Racially Diverse Families
RECRUITING
-
The Effects of Cannabigerol on Attention-Deficit/Hyperactivity Disorder
RECRUITING · Phase 2
-
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
RECRUITING · Phase 4
-
An Open-Label Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jornay PM (Methylphenidate Hydrochloride Extended-Release Capsules) on Adult ADHD Symptoms and Executive Function and Emotional Regulation Throughout the Day Into Early Evening
RECRUITING · Phase 4
-
A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder.
ACTIVE NOT RECRUITING · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.